secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonnet BioTherapeutics Holdings, Inc. (—)
CIK:        0001106838
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001493152-23-008889
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonnet BioTherapeutics receives Nasdaq minimum bid price deficiency notice
--------------------------------------------------------------------------

- Closing bid price of SONN common stock below $1.00 for 30 consecutive business days triggers Nasdaq deficiency notice on March 23, 2023.
- Company has 180 calendar days, until September 19, 2023, to regain compliance by closing at $1.00 for 10 consecutive business days.
- Previously, Nasdaq notified SONN of stockholders' equity deficiency; after February 2023 public offering netting ~$13.5 million, company believes equity requirement is met.
- If bid price compliance not regained, Nasdaq may allow second 180-day period if other listing standards are met, otherwise delisting proceedings may begin.
- Delisting could adversely affect market price, liquidity, and ability to raise capital; penny stock rules may apply if trading below $5.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106838/000149315223008889/0001493152-23-008889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106838/000149315223008889/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-008889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer